Abstract
Objective: To investigate the prognostic values of the preoperative modified Glasgow Prognostic Score (mGPS) and carcinoembryonic antigen (CEA) alone and combined in elderly patients with colorectal cancer (CRC) planning to receive curative surgery. Methods: We retrospectively analyzed 130 elderly patients (aged ≥80 years) with CRC who received curative surgery between 2008 and 2016. The preoperative mGPS and CEA levels were calculated. Results: Elevated preoperative mGPS or CEA level was significantly associated with shorter relapse-free survival (p = 0.005, both) and cancer-specific survival (p = 0.011 and p < 0.001, respectively). Combined use of these two factors improved the predictive accuracy for tumor recurrence relative to that of either factor. Conclusion: Both mGPS and CEA were independent prognostic factors of CRC in elderly patients receiving curative surgery, but their combination was more accurate.
Journal Section:
Research Article
References
1.
Bray
F
, Ferlay
J
, Soerjomataram
I
, Siegel
RL
, Torre
LA
, Jemal
A
. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
. CA Cancer J Clin
. 2018
Nov
;68
(6
):394
–424
.
[PubMed]
0007-92352.
Lu
X
, Guo
W
, Xu
W
, Zhang
X
, Shi
Z
, Zheng
L
, et al.. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients
. Cancer Manag Res
. 2018
Dec
;11
:229
–49
.
[PubMed]
1179-13223.
Petrelli
F
, Barni
S
, Coinu
A
, Bertocchi
P
, Borgonovo
K
, Cabiddu
M
, et al.. The Modified Glasgow Prognostic Score and Survival in Colorectal Cancer: A Pooled Analysis of the Literature
. Rev Recent Clin Trials
. 2015
;10
(2
):135
–41
.
[PubMed]
1574-88714.
McMillan
DC
. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
. Proc Nutr Soc
. 2008
Aug
;67
(3
):257
–62
.
[PubMed]
0029-66515.
Jamieson
NB
, Denley
SM
, Logue
J
, MacKenzie
DJ
, Foulis
AK
, Dickson
EJ
, et al.. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma
. Ann Surg Oncol
. 2011
Aug
;18
(8
):2318
–28
.
[PubMed]
1068-92656.
Al Murri
AM
, Bartlett
JM
, Canney
PA
, Doughty
JC
, Wilson
C
, McMillan
DC
. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
. Br J Cancer
. 2006
Jan
;94
(2
):227
–30
.
[PubMed]
0007-09207.
Forrest
LM
, McMillan
DC
, McArdle
CS
, Angerson
WJ
, Dagg
K
, Scott
HR
. A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer
. Br J Cancer
. 2005
May
;92
(10
):1834
–6
.
[PubMed]
0007-09208.
Adachi
T
, Hinoi
T
, Hattori
M
, Egi
H
, Shimomura
M
, Saito
Y
, et al.. The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer
. Surg Today
. 2015
Nov
;45
(11
):1396
–403
.
[PubMed]
0941-12919.
Jia
J
, Zhang
P
, Gou
M
, Yang
F
, Qian
N
, Dai
G
. The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer
. Dis Markers
. 2019
Jan
;2019
:6812045
.
[PubMed]
0278-024010.
Wang
J
, Wang
X
, Yu
F
, Chen
J
, Zhao
S
, Zhang
D
, et al.. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients
. Int J Clin Exp Pathol
. 2015
Nov
;8
(11
):14853
–63
.
[PubMed]
1936-262511.
McMillan
DC
, Crozier
JE
, Canna
K
, Angerson
WJ
, McArdle
CS
. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer
. Int J Colorectal Dis
. 2007
Aug
;22
(8
):881
–6
.
[PubMed]
0179-195812.
Kanda
Y
. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
. Bone Marrow Transplant
. 2013
Mar
;48
(3
):452
–8
.
[PubMed]
0268-336913.
Song
A
, Eo
W
, Lee
S
. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients
. World J Gastroenterol
. 2015
Nov
;21
(43
):12410
–20
.
[PubMed]
1007-932714.
Eren
T
, Burcu
B
, Tombalak
E
, Ozdemir
T
, Leblebici
M
, Ozemir
IA
, et al.. Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery
. J Gastrointest Surg
. 2016
Jun
;20
(6
):1231
–8
.
[PubMed]
1091-255X15.
Kobayashi
T
, Teruya
M
, Kishiki
T
, Endo
D
, Takenaka
Y
, Tanaka
H
, et al.. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma
. Surgery
. 2008
Nov
;144
(5
):729
–35
.
[PubMed]
0039-606016.
Nazha
B
, Moussaly
E
, Zaarour
M
, Weerasinghe
C
, Azab
B
. Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate
. World J Gastrointest Surg
. 2015
Dec
;7
(12
):370
–7
.
[PubMed]
1948-936617.
Park
YJ
, Park
KJ
, Park
JG
, Lee
KU
, Choe
KJ
, Kim
JP
. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases
. World J Surg
. 1999
Jul
;23
(7
):721
–6
.
[PubMed]
0364-231318.
Sun
LC
, Chu
KS
, Cheng
SC
, Lu
CY
, Kuo
CH
, Hsieh
JS
, et al.. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
. BMC Cancer
. 2009
Aug
;9
(1
):288
.
[PubMed]
1471-240719.
Huh
JW
, Oh
BR
, Kim
HR
, Kim
YJ
. Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer
. J Surg Oncol
. 2010
Apr
;101
(5
):396
–400
.
[PubMed]
0022-479020.
World Medical Association
. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects
. JAMA
. 2013
Nov
;310
(20
):2191
–4
.
[PubMed]
0098-7484© 2020 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2020
You do not currently have access to this content.
